Escorting Octogenarian for Gastric Cancer Surgery
Sponsor
Ruijin Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03639792
Collaborator
(none)
61
1
24
2.5
Study Details
Study Description
Brief Summary
An objective analysis of postoperative complications is vital to escort octogenarian for gastric cancer surgery. Investigator carefully collected clinical data prospectively to pave way for standard management in high risk patients.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
An objective analysis of postoperative complications is vital to escort octogenarian for gastric cancer surgery. Investigator carefully collected clinical data prospectively to pave way for standard management in high risk patients. Detailed data on surgical indication, assessment for proposed surgery and perioperative management are analyzed for future guidelines in senile.
Study Design
Study Type:
Observational
Actual Enrollment
:
61 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Escorting Octogenarian for Gastric Cancer Surgery
Actual Study Start Date
:
Jan 1, 2016
Actual Primary Completion Date
:
Dec 31, 2017
Actual Study Completion Date
:
Dec 31, 2017
Outcome Measures
Primary Outcome Measures
- Postoperative Morbidity and mortality [One month after hospital discharge]
Postoperative Morbidity and mortality according to standard definition
Secondary Outcome Measures
- Overall survival [upto two years]
Overall survival
Eligibility Criteria
Criteria
Ages Eligible for Study:
80 Years
to 90 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
- Pathologically confirmed gastric cancer patients Clinically fit for gastric cancer surgery
Exclusion Criteria:
- Non gastric cancer patients Clinically unfit for gastric cancer surgery
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Ruijin Hospital Shanghai Jiaotong University School of Medicine | Shanghai | Shanghai | China | 200025 |
Sponsors and Collaborators
- Ruijin Hospital
Investigators
- Principal Investigator: Birendra K Sah, Ph D, Ruijin Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
BIRENDRA KUMAR SAH,
Surgeon,
Ruijin Hospital
ClinicalTrials.gov Identifier:
NCT03639792
Other Study ID Numbers:
- RJ-GC-Postop-complication 2
First Posted:
Aug 21, 2018
Last Update Posted:
May 22, 2020
Last Verified:
Aug 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by BIRENDRA KUMAR SAH,
Surgeon,
Ruijin Hospital
Additional relevant MeSH terms: